However, the firm distributed dividends of 54 cents per share during the first quarter of the year, a value that reflects the profits obtained in the areas of agriculture, nutrition and pharmaceuticals.
Earnings in the first quarter of the year totaled US$488 million, which shows a decrease of 59% compared to the same period in 2008. However, the goal of reducing fixed costs in 2009 increased to $1 billion, while the capital expenditure plan was reduced by $200 million to $1.4 billion.
The company said in a statement that the pre-tax losses of $19 million reflect low sales volume and an unfavorable monetary impact, partly offset by fixed costs and high local prices.
Leave your comment